Metraipolis › archive › dc_1bdbedcff935
Relative Impact of GLP-1 Agonist Use on Microvascular Versus Macrovascular Complications — Europe PMC PMID:41147020
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41147020
- DOI
- 10.7759/cureus.93925
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T13:31:13.454Z
- SHA-256 of the archived text
0a3c571ce96fb7ee83bd7dfbff009fdfbd84646315dad90df5e0405537aec198- Stable URL of this page
https://metraipolis.com/documento/dc_1bdbedcff935
How to cite
Relative Impact of GLP-1 Agonist Use on Microvascular Versus Macrovascular Complications — Europe PMC PMID:41147020 — Europe PMC (en), https://europepmc.org/article/MED/41147020 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_1bdbedcff935 (Metraipolis archive dc_1bdbedcff935, sha256 0a3c571ce96fb7ee83bd7dfbff009fdfbd84646315dad90df5e0405537aec198)
BibTeX
@misc{dc1bdbedcff935,
title = {Relative Impact of GLP-1 Agonist Use on Microvascular Versus Macrovascular Complications — Europe PMC PMID:41147020},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41147020},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_1bdbedcff935; sha256 0a3c571ce96fb7ee83bd7dfbff009fdfbd84646315dad90df5e0405537aec198},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41147020. Agents can read the archived copy with the MCP tool read_document.